Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials

γδ T lymphocytes represent an emerging class of cellular immunotherapy with preclinical promise to treat cancer, notably neuroblastoma. The innate-like immune cell subset demonstrates inherent cytoxicity toward tumor cells independent of MHC recognition, enabling allogeneic administration of healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonus, Hunter C., Burnham, Rebecca E., Ho, Andrew, Pilgrim, Adeiye A., Shim, Jenny, Doering, Christopher B., Spencer, H. Trent, Goldsmith, Kelly C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966991/
https://www.ncbi.nlm.nih.gov/pubmed/35371623
http://dx.doi.org/10.1080/2162402X.2022.2057012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966991/
https://www.ncbi.nlm.nih.gov/pubmed/35371623
http://dx.doi.org/10.1080/2162402X.2022.2057012

Ejemplares similares